{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:25:01Z","timestamp":1759937101508,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10067-023-06613-9","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T09:02:17Z","timestamp":1682931737000},"page":"2105-2114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-1576","authenticated-orcid":false,"given":"Epit\u00e1cio D. S.","family":"Neto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taurino S. R.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo G. M.","family":"Balbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex H.","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio Luiz R.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloisa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danieli C. O.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro C.","family":"Zacharias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"6613_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"6613_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","volume":"96","author":"JL Vianna","year":"1994","unstructured":"Vianna JL, Khamashta MA, Ordi-Ros J et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 96:3\u20139. https:\/\/doi.org\/10.1016\/0002-9343(94)90108-2","journal-title":"Am J Med"},{"key":"6613_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"JS Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752\u2013763. https:\/\/doi.org\/10.1056\/NEJMra002974","journal-title":"N Engl J Med"},{"issue":"8","key":"6613_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.autrev.2018.01.027","volume":"17","author":"C Belizna","year":"2018","unstructured":"Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L et al (2018) Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: are they different entities? Autoimmun Rev 17(8):739\u2013745. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.027","journal-title":"Autoimmun Rev"},{"issue":"12","key":"6613_CR5","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1177\/0961203320949667","volume":"29","author":"AM de Franco","year":"2020","unstructured":"de Franco AM, Medina FMC, Balbi GGM, Levy RA, Signorelli F (2020) Ophthalmologic manifestations in primary antiphospholipid syndrome patients: a cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature. Lupus 29(12):1528\u20131543. https:\/\/doi.org\/10.1177\/0961203320949667","journal-title":"Lupus"},{"issue":"6","key":"6613_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/s0002-9394(99)00311-6","volume":"128","author":"R Cobo-Soriano","year":"1999","unstructured":"Cobo-Soriano R, S\u00e1nchez-Ram\u00f3n S, Aparicio MJ, Teijeiro MA, Vidal P, Su\u00e1rez-Leoz M et al (1999) Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 128(6):725\u2013732. https:\/\/doi.org\/10.1016\/s0002-9394(99)00311-6","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"6613_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3928\/23258160-20170130-13","volume":"48","author":"MGJ Trese","year":"2017","unstructured":"Trese MGJ, Thanos A, Yonekawa Y, Randhawa S (2017) Optical coherence tomography angiography of paracentral acute middle maculopathy associated with primary antiphospholipid syndrome. Ophthalmic Surg Lasers Imaging Retina 48(2):175\u2013178. https:\/\/doi.org\/10.3928\/23258160-20170130-13","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"10","key":"6613_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2013.4056","volume":"131","author":"D Sarraf","year":"2013","unstructured":"Sarraf D, Rahimy E, Fawzi AA et al (2013) Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol 131(10):1275\u20131287. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.4056","journal-title":"JAMA Ophthalmol"},{"key":"6613_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/bjophthalmol-2015-306629","volume":"100","author":"S Silpa-archa","year":"2016","unstructured":"Silpa-archa S, Lee JJ, Foster CS (2016) Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol 100:135\u2013141. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306629","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"6613_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.sjopt.2016.02.001","volume":"30","author":"SS Shoughy","year":"2016","unstructured":"Shoughy SS, Tabbara KF (2016) Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol 30(2):117\u2013121. https:\/\/doi.org\/10.1016\/j.sjopt.2016.02.001","journal-title":"Saudi J Ophthalmol"},{"key":"6613_CR11","doi-asserted-by":"publisher","unstructured":"- Pelegr\u00edn L, Morat\u00f3 M, Ara\u00fajo O, Figueras-Roca M, Zarranz-Ventura J, Ad\u00e1n A et al (2022) Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography. Rheumatology keac626. https:\/\/doi.org\/10.1093\/rheumatology\/keac626","DOI":"10.1093\/rheumatology\/keac626"},{"key":"6613_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00417-020-04626-7","volume":"258","author":"SA Arfeen","year":"2020","unstructured":"Arfeen SA, Bahgat N, Adel N, Eissa M, Khafagy MM (2020) Assessment of superficial and deep retinal vessel density in systemic lupus erythematosus patients using optical coherence tomography angiography. Graefe\u2019s Arch Clin Exp Ophthalmol 258:1261\u20131268. https:\/\/doi.org\/10.1007\/s00417-020-04626-7","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"9","key":"6613_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6613_CR14","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288","journal-title":"J Rheumatol"},{"key":"6613_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363\u2013369. https:\/\/doi.org\/10.1002\/art.1780390303","journal-title":"Arthritis Rheum"},{"issue":"9","key":"6613_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1177\/09612033155768","volume":"24","author":"M-C Amigo","year":"2015","unstructured":"Amigo M-C, Goycochea-Robles MV, Espinosa-Cuervo G, Medina G, Barrag\u00e1n-Garfias JA, Vargas A et al (2015) Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS). Lupus 24(9):927\u2013934. https:\/\/doi.org\/10.1177\/09612033155768","journal-title":"Lupus"},{"issue":"6","key":"6613_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archopht.1993.01090060119035","volume":"111","author":"LT Chylack","year":"1993","unstructured":"Chylack LT, Wolfe JK, Singer DM et al (1993) The lens opacities classification system III. Arch Ophthalmol 111(6):831\u2013836. https:\/\/doi.org\/10.1001\/archopht.1993.01090060119035","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"6613_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.maturitas.2013.01.018","volume":"75","author":"VB Voleti","year":"2013","unstructured":"Voleti VB, Hubschman J-P (2013) Age-related eye disease. Maturitas 75(1):29\u201333. https:\/\/doi.org\/10.1016\/j.maturitas.2013.01.018","journal-title":"Maturitas"},{"issue":"9","key":"6613_CR19","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/art.1780290914","volume":"29","author":"AV Klinkhoff","year":"1986","unstructured":"Klinkhoff AV, Beattie CW, Chalmers A (1986) Retinopathy in systemic lupus erythematosus: relationship to disease activity. Arthritis Rheum 29(9):1152\u20131156. https:\/\/doi.org\/10.1002\/art.1780290914","journal-title":"Arthritis Rheum"},{"issue":"6","key":"6613_CR20","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TYY, Melles RB, Mieler WF (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmol 123(6):1386\u20131394. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.058","journal-title":"Ophthalmol"},{"key":"6613_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1\u201355. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.11.003","journal-title":"Prog Retin Eye Res"},{"key":"6613_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/09273940490895308","volume":"12","author":"RW Read","year":"2004","unstructured":"Read RW (2004) Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm 12:87\u201399. https:\/\/doi.org\/10.1080\/09273940490895308","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"6613_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00296-014-3129-5","volume":"35","author":"K Alderaan","year":"2015","unstructured":"Alderaan K, Sekicki V, Magder LS, Petri M (2015) Risk factors for cataracts in systemic lupus erythematosus (SLE). Rheumatol Int 35(4):701\u2013708. https:\/\/doi.org\/10.1007\/s00296-014-3129-5","journal-title":"Rheumatol Int"},{"key":"6613_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.autrev.2018.01.011","volume":"17","author":"A Dias-Santos","year":"2018","unstructured":"Dias-Santos A, Proenca RP, Tavares Ferreira J et al (2018) The role of ophthalmic imaging in central nervous system degeneration in systemic lupus erythematosus. Autoimmun Rev 17:617\u2013624. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.011","journal-title":"Autoimmun Rev"},{"issue":"11","key":"6613_CR25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/bjo.56.11.800","volume":"56","author":"D Gold","year":"1972","unstructured":"Gold D, Morris D, Henkind P (1972) Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 56(11):800. https:\/\/doi.org\/10.1136\/bjo.56.11.800","journal-title":"Br J Ophthalmol"},{"key":"6613_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/bjo.2010.182857","volume":"95","author":"VM Utz","year":"2011","unstructured":"Utz VM, Tang J (2011) Ocular manifestations of the antiphospholipid syndrome. Br J Ophthalmol 95:454\u2013459. https:\/\/doi.org\/10.1136\/bjo.2010.182857","journal-title":"Br J Ophthalmol"},{"key":"6613_CR27","doi-asserted-by":"publisher","first-page":"0157536","DOI":"10.1371\/journal.pone.0157536","volume":"11","author":"W Zhu","year":"2016","unstructured":"Zhu W, Wu Y, Xu M et al (2016) Correction: antiphospholipid antibody and risk of retinal vein occlusion: a systematic review and meta-analysis. PLoS One 11:0157536. https:\/\/doi.org\/10.1371\/journal.pone.0157536","journal-title":"PLoS One"},{"issue":"6","key":"6613_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamaophthalmol.2014.387","volume":"132","author":"DR Lally","year":"2014","unstructured":"Lally DR, Baumal C (2014) Subretinal drusenoid deposits associated with complement- mediated IgA nephropathy. JAMA Ophthalmol 132(6):775\u2013777. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.387","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"6613_CR29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/bjo.2007.130138","volume":"92","author":"Y D\u2019souza","year":"2008","unstructured":"D\u2019souza Y, Short CD, McLeod D, Bonshek RE (2008) Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis. Br J Ophthalmol 92(7):950\u2013953. https:\/\/doi.org\/10.1136\/bjo.2007.130138","journal-title":"Br J Ophthalmol"},{"key":"6613_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajo.2016.11.014","volume":"175","author":"A Invernizzi","year":"2017","unstructured":"Invernizzi A, dell\u2019Arti L, Leone G, Galimberti D, Garoli E, Moroni G, Santaniello A, Agarwal A, Viola F (2017) Drusen-like deposits in young adults diagnosed with systemic lupus erythematosus. Am J Ophthalmol 175:68\u201376. https:\/\/doi.org\/10.1016\/j.ajo.2016.11.014","journal-title":"Am J Ophthalmol"},{"key":"6613_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/eye.2001.142","volume":"15","author":"RF Mullins","year":"2001","unstructured":"Mullins RF, Aptsiauri N, Hageman GS (2001) Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye 15:390\u2013395. https:\/\/doi.org\/10.1038\/eye.2001.142","journal-title":"Eye"},{"issue":"1","key":"6613_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/ICB.0000000000000164","volume":"10","author":"LA Dalvin","year":"2016","unstructured":"Dalvin LA, Fervenza FC, Sethi S, Pulido JS (2016) Shedding light on fundus drusen associated with membranoproliferative glomerulonephritis: breaking stereotypes of types I, II, and III. Retin Cases Brief Rep 10(1):72\u201378. https:\/\/doi.org\/10.1097\/ICB.0000000000000164","journal-title":"Retin Cases Brief Rep"},{"issue":"1","key":"6613_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB (2019) Pachychoroid Disease Eye 33(1):14\u201333. https:\/\/doi.org\/10.1038\/s41433-018-0158-4","journal-title":"Pachychoroid Disease Eye"},{"key":"6613_CR34","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.2147\/OPTH.S59452","volume":"8","author":"D Goodwin","year":"2014","unstructured":"Goodwin D (2014) Homonymous hemianopia: challenges and solutions. Clin Ophthalmol 8:1919\u20131927. https:\/\/doi.org\/10.2147\/OPTH.S59452","journal-title":"Clin Ophthalmol"},{"key":"6613_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ajoc.2018.03.001","volume":"10","author":"HK Yang","year":"2018","unstructured":"Yang HK, Moon KW, Ji MJ, Han SB, Hwang JM (2018) Primary antiphospholipid syndrome presenting with homonymous quadrantanopsia. Am J Ophthalmol Case Reports 10:208\u2013210. https:\/\/doi.org\/10.1016\/j.ajoc.2018.03.001","journal-title":"Am J Ophthalmol Case Reports"},{"key":"6613_CR36","doi-asserted-by":"publisher","first-page":"100884","DOI":"10.1016\/j.preteyeres.2020.100884","volume":"81","author":"J Scharf","year":"2021","unstructured":"Scharf J, Freund KB, Sadda S, Sarraf D (2021) Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res 81:100884. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100884","journal-title":"Prog Retin Eye Res"},{"key":"6613_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/IMCRJ.S196047","volume":"12","author":"M Nakamura","year":"2019","unstructured":"Nakamura M, Katagiri S, Hayashi T et al (2019) Longitudinal follow-up of two patients with isolated paracentral acute middle maculopathy. Int Med Case Rep J 12:143\u2013149. https:\/\/doi.org\/10.2147\/IMCRJ.S196047","journal-title":"Int Med Case Rep J"},{"issue":"12","key":"6613_CR38","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00417-020-04826-1","volume":"258","author":"N Moura-Coelho","year":"2020","unstructured":"Moura-Coelho N, Gaspar T, Ferreira JT, Dutra-Medeiros M, Cunha JP (2020) Paracentral acute middle maculopathy-review of the literature. Graefes Arch Clin Exp Ophthalmol 258(12):2583\u20132596. https:\/\/doi.org\/10.1007\/s00417-020-04826-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6613_CR39","doi-asserted-by":"publisher","first-page":"7589841","DOI":"10.1155\/2019\/7589841","volume":"2019","author":"F Scarinci","year":"2019","unstructured":"Scarinci F, Varano M, Parravano M (2019) Retinal sensitivity loss correlates with deep capillary plexus impairment in diabetic macular ischemia. J Ophthalmol 2019:7589841. https:\/\/doi.org\/10.1155\/2019\/7589841","journal-title":"J Ophthalmol"},{"issue":"14","key":"6613_CR40","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1177\/09612033221133687","volume":"31","author":"TS Neto","year":"2022","unstructured":"Neto TS, Neto ED, Balbi GG, Signorelli F, Higashi AH, Monteiro MLR et al (2022) Ocular findings in asymptomatic patients with primary antiphospholipid syndrome. Lupus 31(14):1800\u20131807. https:\/\/doi.org\/10.1177\/09612033221133687","journal-title":"Lupus"},{"issue":"2","key":"6613_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/24725625.2021.1893961","volume":"5","author":"D Chin","year":"2021","unstructured":"Chin D, Gan NY, Holder GE, Tien M, Agrawal R, Manghani M (2021) Severe retinal vasculitis in systemic lupus erythematosus leading to vision threatening paracentral acute middle maculopathy. Mod Rheumatol Case Rep 5(2):265\u2013271. https:\/\/doi.org\/10.1080\/24725625.2021.1893961","journal-title":"Mod Rheumatol Case Rep"},{"key":"6613_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ajo.2018.09.002","volume":"197","author":"AA Jammal","year":"2019","unstructured":"Jammal AA, Ogata NG, Daga FB, Abe RY, Costa VP, Medeiros FA (2019) What is the amount of visual field loss associated with disability in glaucoma? Am J Ophthalmol 197:45\u201352. https:\/\/doi.org\/10.1016\/j.ajo.2018.09.002","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"6613_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","volume":"8","author":"V Pengo","year":"2010","unstructured":"Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 8(2):237\u2013242. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03674.x","journal-title":"J Thromb Haemost"},{"issue":"17","key":"6613_CR44","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","volume":"118","author":"V Pengo","year":"2011","unstructured":"Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F et al (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118(17):4714\u20134718. https:\/\/doi.org\/10.1182\/blood-2011-03-340232","journal-title":"Blood"},{"issue":"3","key":"6613_CR45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.semarthrit.2019.04.009","volume":"49","author":"M Radin","year":"2019","unstructured":"Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A et al (2019) The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort. Semin Arthritis Rheum 49(3):464\u2013468. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.04.009","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06613-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:10:58Z","timestamp":1689232258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06613-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["6613"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06613-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"16 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}